1-56917642-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000562.3(C8A):​c.1681G>C​(p.Glu561Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.062 in 1,614,138 control chromosomes in the GnomAD database, including 4,774 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. E561E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.10 ( 1252 hom., cov: 33)
Exomes 𝑓: 0.058 ( 3522 hom. )

Consequence

C8A
NM_000562.3 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.989

Publications

19 publications found
Variant links:
Genes affected
C8A (HGNC:1352): (complement C8 alpha chain) C8 is a component of the complement system and contains three polypeptides, alpha, beta and gamma. This gene encodes the alpha subunit of C8. C8 participates in the formation of the membrane attack complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause complement C8 alpha-gamma deficiency. [provided by RefSeq, Nov 2008]
C8A Gene-Disease associations (from GenCC):
  • type I complement component 8 deficiency
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046334267).
BP6
Variant 1-56917642-G-C is Benign according to our data. Variant chr1-56917642-G-C is described in ClinVar as Benign. ClinVar VariationId is 402464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.212 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C8ANM_000562.3 linkc.1681G>C p.Glu561Gln missense_variant Exon 11 of 11 ENST00000361249.4 NP_000553.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C8AENST00000361249.4 linkc.1681G>C p.Glu561Gln missense_variant Exon 11 of 11 1 NM_000562.3 ENSP00000354458.3

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
15578
AN:
152160
Hom.:
1250
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.216
Gnomad AMI
AF:
0.0482
Gnomad AMR
AF:
0.108
Gnomad ASJ
AF:
0.0415
Gnomad EAS
AF:
0.0520
Gnomad SAS
AF:
0.138
Gnomad FIN
AF:
0.0471
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.0457
Gnomad OTH
AF:
0.104
GnomAD2 exomes
AF:
0.0755
AC:
18974
AN:
251252
AF XY:
0.0751
show subpopulations
Gnomad AFR exome
AF:
0.224
Gnomad AMR exome
AF:
0.0916
Gnomad ASJ exome
AF:
0.0454
Gnomad EAS exome
AF:
0.0517
Gnomad FIN exome
AF:
0.0483
Gnomad NFE exome
AF:
0.0454
Gnomad OTH exome
AF:
0.0711
GnomAD4 exome
AF:
0.0578
AC:
84516
AN:
1461860
Hom.:
3522
Cov.:
31
AF XY:
0.0595
AC XY:
43306
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.227
AC:
7616
AN:
33478
American (AMR)
AF:
0.0927
AC:
4146
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0430
AC:
1125
AN:
26136
East Asian (EAS)
AF:
0.0650
AC:
2579
AN:
39698
South Asian (SAS)
AF:
0.132
AC:
11423
AN:
86256
European-Finnish (FIN)
AF:
0.0459
AC:
2451
AN:
53420
Middle Eastern (MID)
AF:
0.112
AC:
645
AN:
5762
European-Non Finnish (NFE)
AF:
0.0454
AC:
50436
AN:
1111990
Other (OTH)
AF:
0.0678
AC:
4095
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
4248
8496
12743
16991
21239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2080
4160
6240
8320
10400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.102
AC:
15600
AN:
152278
Hom.:
1252
Cov.:
33
AF XY:
0.102
AC XY:
7595
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.216
AC:
8961
AN:
41532
American (AMR)
AF:
0.108
AC:
1659
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0415
AC:
144
AN:
3472
East Asian (EAS)
AF:
0.0519
AC:
268
AN:
5166
South Asian (SAS)
AF:
0.138
AC:
666
AN:
4822
European-Finnish (FIN)
AF:
0.0471
AC:
500
AN:
10626
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.0457
AC:
3107
AN:
68034
Other (OTH)
AF:
0.103
AC:
217
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
653
1305
1958
2610
3263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0530
Hom.:
240
Bravo
AF:
0.110
TwinsUK
AF:
0.0485
AC:
180
ALSPAC
AF:
0.0431
AC:
166
ESP6500AA
AF:
0.205
AC:
903
ESP6500EA
AF:
0.0473
AC:
407
ExAC
AF:
0.0774
AC:
9393
Asia WGS
AF:
0.107
AC:
373
AN:
3478
EpiCase
AF:
0.0478
EpiControl
AF:
0.0510

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
11
DANN
Uncertain
0.98
DEOGEN2
Benign
0.018
T
Eigen
Benign
-0.48
Eigen_PC
Benign
-0.30
FATHMM_MKL
Benign
0.64
D
LIST_S2
Uncertain
0.95
D
MetaRNN
Benign
0.0046
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.56
N
PhyloP100
0.99
PrimateAI
Benign
0.24
T
PROVEAN
Benign
0.33
N
REVEL
Benign
0.023
Sift
Benign
0.55
T
Sift4G
Benign
0.76
T
Polyphen
0.063
B
Vest4
0.017
MPC
0.034
ClinPred
0.0062
T
GERP RS
2.7
Varity_R
0.11
gMVP
0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1342440; hg19: chr1-57383315; COSMIC: COSV63484457; API